Literature DB >> 20577296

Coronary artery disease: revascularization strategies for patients with CAD and diabetes.

G Robert Myers1, William S Weintraub.   

Abstract

CABG surgery has been considered the optimal revascularization strategy for patients with diabetes mellitus who have lexft main and/or multivessel coronary artery disease. The results of a new analysis of data from the SYNTAX trial challenge this conventional wisdom and highlight additional coronary revascularization options to physicians and patients.

Entities:  

Mesh：

Year:  2010        PMID： 20577296     DOI： 10.1038/nrcardio.2010.82

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


  9 in total

1.  Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)

Authors: 
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Percutaneous coronary intervention, diabetes mellitus, and death.

Authors:  Harold L Dauerman
Journal:  J Am Coll Cardiol       Date:  2010-01-14       Impact factor: 24.094

Review 3.  Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction.

Authors:  A J Nordmann; H Bucher; P Hengstler; T Harr; J Young
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

5.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

6.  Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.

Authors:  Adrian P Banning; Stephen Westaby; Marie-Claude Morice; A Pieter Kappetein; Friedrich W Mohr; Sergio Berti; Mattia Glauber; Mirle A Kellett; Robert S Kramer; Katrin Leadley; Keith D Dawkins; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2010-01-14       Impact factor: 24.094

7.  Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.

Authors:  Joost Daemen; Eric Boersma; Marcus Flather; Jean Booth; Rod Stables; Alfredo Rodriguez; Gaston Rodriguez-Granillo; Whady A Hueb; Pedro A Lemos; Patrick W Serruys
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

8.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

Authors:  Mark A Hlatky; Derek B Boothroyd; Dena M Bravata; Eric Boersma; Jean Booth; Maria M Brooks; Didier Carrié; Tim C Clayton; Nicolas Danchin; Marcus Flather; Christian W Hamm; Whady A Hueb; Jan Kähler; Sheryl F Kelsey; Spencer B King; Andrzej S Kosinski; Neuza Lopes; Kathryn M McDonald; Alfredo Rodriguez; Patrick Serruys; Ulrich Sigwart; Rodney H Stables; Douglas K Owens; Stuart J Pocock
Journal:  Lancet       Date:  2009-03-19       Impact factor: 79.321

9.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094
  9 in total
  3 in total

1.  KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.

Authors:  Bo-Fang Zhang; Hong Jiang; Jing Chen; Xin Guo; Qi Hu; Shuo Yang
Journal:  Int J Mol Med       Date:  2017-12-29       Impact factor: 4.101

2.  The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study.

Authors:  Yuan Li; Zhi-Gang Yang; Jin Wang; Ying-Kun Guo; Shan Huang; Rui Shi; Wei-Feng Yan; Wen-Lei Qian; Guang-Xi He
Journal:  Cardiovasc Diabetol       Date:  2022-02-22       Impact factor: 9.951

3.  In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions.

Authors:  Yuanmin Li; Jing Ni; Rong Guo; Weiming Li
Journal:  Biomed Res Int       Date:  2016-03-31       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.